The story of AstraZeneca's adventures in vaccines and politics is impossible to separate from the background of the man in charge. As one of his competitors put it: "Astra is Pascal's company ...

GlobalData is the parent company of Clinical Trials Arena. Sharon Barr, executive vice president of biopharmaceuticals R&D at ...

AstraZeneca received Food and Drug Administration approval for enhertu, its breast cancer treatment developed in partnership with Japanese company Daiichi Sankyo.

Understanding the enormous commercial potential of this market, the company continues to actively expand its portfolio of FDA-approved and experimental drugs. Overall, sales of AstraZeneca's ...

CAMBRIDGE, England, November 12, 2024--AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint ...

For this reason, we prefer to remain neutral. Since our last update, when we downgraded AstraZeneca's (NASDAQ:AZN) rating to Neutral, the company's stock price has declined (Fig 1). Over the ...